The Radboud University Medical Center, is the teaching hospital affiliated with the Radboud University Nijmegen, in the city of Nijmegen in the eastern-central part of the Netherlands. The Radboud University Medical Center was founded in 1956.

There are 1,065 beds in Intensive Care Medicine, Radboud University Nijmegen Medical Centre.

During the past decade, Intensive Care Medicine, Radboud University Nijmegen Medical Centre conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Intensive Care Medicine, Radboud University Nijmegen Medical Centre" #1 collaborator was "Exponential Biotherapies Inc." with 2 trials as a collaborator, "Erasmus Medical Center" with 1 trials as a collaborator and "UMC Utrecht" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Intensive Care Medicine, Radboud University Nijmegen Medical Centre" are "Endotoxemia" (4 trials), "Autoimmune Diseases" (3 trials), "Delirium" (2 trials), "Postoperative Cognitive Dysfunction" (2 trials) and "Cold Exposure" (1 trials). Many other conditions were trialed in "Intensive Care Medicine, Radboud University Nijmegen Medical Centre" in a lesser frequency.

Most popular intervention types in "Intensive Care Medicine, Radboud University Nijmegen Medical Centre" are "Drug" (6 trials), "Behavioral" (3 trials), "Biological" (2 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "EA-230" (2 trials), "18F-DPA-714 PET/CT neuroimaging" (1 trials), "Acetylsalicylic acid lysinate" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Intensive Care Medicine, Radboud University Nijmegen Medical Centre" are 8 trials for "Male" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "Intensive Care Medicine, Radboud University Nijmegen Medical Centre". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Intensive Care Medicine, Radboud University Nijmegen Medical Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Intensive Care Medicine, Radboud University Nijmegen Medical Centre, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".